Difference of serum levels of type iv collagen 7s between early or overt nephropathy and nondiabetic renal disease in diabetic patients with micro-or macroalbuminuria?

Nephron

Volumn 73, Issue 4, 1996, Pages 601-605

  Inomata, S ^a   Itoh, M ^b   Sato, T ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

Early diabetic nephropathy; Microalbuminuria; Nephrosclerosis; Nondiabetic renal disease; Type IV collagen 7S

Indexed keywords

COLLAGEN TYPE 4;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NEPHROSCLEROSIS; PRIORITY JOURNAL; PROTEINURIA;

AGED; ALBUMINURIA; BIOLOGICAL MARKERS; COLLAGEN; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; NEPHROSCLEROSIS;

EID: 0029757359     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189147     Document Type: Article

References (23)

1. Cordonnier D. Bayle F. Benhamou P-Y, Mi-longo R. Zaoui P. Maynard C. Halimi S: Future trends of management of renal failure in diabetics. Kidney Int 1993:43(suppl 4):S8-S13.
2. Feldt-Rasmussen B. Mathiesen ER. Dcckert T: Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes mellitus. Lancet 1986:ii: 1300-1304.
3. Reichard P, Nilsson B-Y. Roscnqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-309.
4. Marre M, Chatellier G, Leblanc H. Guvene TT. Menard J. Passa P: Prevention of diabetic nephropathy with enalapri! in normotensive diabetics with microalbuminuria. Br Med J 1988:297:1092-1095.
5. Mathiesen ER, Homme! E, Giese J. Pars ing H-H: Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. Br Med J 1991:303:81-87.
6. Inomata S. Nakamoto Y. Inoue M. Itoh M. Ohsawa Y. Masamunc O: Relationship between urinary albumin excretion rate and renal histology in non-insulin-dependcnt diabetes mellitus. With reference to the clinical significance of microalbuminuria. J Diabetic Complications 1989;3:172-178.
7. Karttunen T. Risteli J. Aulio-Harmaincn H. Risteli L: Effect of age and diabetes on type IV collagen and laminin in human kidney cortex. Kidney Int 1986:30:586-591.
8. Woodrow D. Moss J. Shore I. Spiro RG: Diabetic glomerulosclerosis-Immunogold ultra-structural studies on the glomerular distribution of type IV’ collagen and heparan sulphate proteoglycan. J Pathol 1992:167:49-58.
9. Danne T. Spiro MJ. Spiro RG: Effect of high glucose on type IV’ collagen production by cultured glomerular epithelial, endothelial, and mcsangial cells. Diabetes 1993;42:170-177.
10. Ledbetter S. Copeland F.J. Noonan D. Vogeri G. Hassel JR.: Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidney and thromboxane synthase inhibition. Diabetes 1990:39:196-203.
11. Haneda M. Kikkawa R. Togawa M. Koya D, Kajiiwara N. Ooshima A, Shigeta Y: Glucose enhances type IV collagen production in cultured rat glomerular mcsangial cells. Diabcto-logia 1991:34:198-200.
12. Ziyadch FN: Renal tubular basement membrane and collagen type IV in diabetes mellitus. Kidney Int 1993:43:114-120.
13. Hasslacher Ch. Reichenbachcr R. Gechter F. Timpl R: Glomerular basement membrane synthesis and serum concentration of type IV collagen in streplozotocin-diabclic rats. Diabe-tologia 1984;26:150-154.
14. Brocks DG. Neubaucr HP. Strccker H: Type IV collagen antigens in serum of diabetic rats: A marker for basement membrane collagen biosynthesis. Diabctologia 1985:28:928-932.
15. Hogemann B. Balleiscn L. Rauterberg J. Voss B. Gerlach U: Basement membrane components (7S collagen, laminin P1) arc increased in sera of diabetics and active platelets in vitro. Haemostasis 1986; 16:428-432.
16. Matsumoto E. Matsumoto G, Ooshima A. Ki-kuoka H. Bcssho H. Miyamura K. Nanjo K: Scrum type IV collagen concentrations in diabetic patients with microangiopathy as determined by enzyme immunoassay with monoclonal antibodies. Diabetes 1990:39:885-890.
17. Hasslacher C. Brocks D. Mann J. Mall G, Waldltcrr R: Influence of hypertension on scrum concentration of type IV collagen antigens in streptozotocin diabetic rats. Diabctologia 1987;30:344-347.
18. McGuire PG. Brocks DG. Killcn PD. Orkin RW: Increased deposition of basement membrane macromolecules in specific vessels of the spontaneously hypertensive rat. Am J Pathol 1989;135:291-298.
19. Martin J. Davies MK. Thomas G. Lovett DH: Human mcsangial cells secrete a GBM-degrad-ing neutral proteinascs and a specific inhibitor. Kidney Int 1989;36:790-801.
20. Davies M. Martin J. Thomas GJ. Lovett DH: Protcinases and glomerular matrix turnover. Kidney Int 1992;41:671-678.
21. Yamamoto T. Nakamura T. Noble NA. Ruos-lahli E, Border WA: Expression of transforming growth factors is elevated in human and experimental diabetic glomerupathv. Proc Natl AcadSci USA 1993:90:1814-1818.
22. Lovett DH. Johnson RJ. Marti H-P. Martin J. Davies M. Couser WG: Structural characterization of the mcsangial cell type IV collage-nasc and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol 1992:141:85-98.
23. Harris RC, Haralson MA. Badr KF: Continuous strctch-rclaxation in culture alters rat mcsangial cell morphology, growth characteristics. and metabolic activity. Lab Invest 1992: 66:548-554.